RESUMO
BACKGROUND: There are significant age and sex effects in cognitive ability and brain disease. However, sex differences in aging of human brain areas associated with nonreproductive behavior have not been extensively studied. We hypothesized that there would be significant sex differences in aging of brain areas that subserve speech, visuospatial, and memory function. METHODS: We investigated sex differences in the effect of aging on human brain morphometry by means of volumetric magnetic resonance imaging and on regional cerebral metabolism for glucose by positron emission tomography. In the magnetic resonance imaging study, we examined 69 healthy right-handed subjects (34 women and 35 men), divided into young (age range, 20 to 35 years) and old (60 to 85 years) groups. In the positron emission tomography study, we investigated 120 healthy right-handed subjects (65 women and 55 men) aged 21 to 91 years. RESULTS: In the magnetic resonance imaging study, age-related volume loss was significantly greater in men than women in whole brain and frontal and temporal lobes, whereas it was greater in women than men in hippocampus and parietal lobes. In the positron emission tomography study, significant sex differences existed in the effect of age on regional brain metabolism, and asymmetry of metabolism, in the temporal and parietal lobes, Broca's area, thalamus, and hippocampus. CONCLUSIONS: We found significant sex differences in aging of brain areas that are essential to higher cognitive functioning. Thus, our findings may explain some of the age-sex differences in human cognition and response to brain injury and disease.
Assuntos
Envelhecimento/metabolismo , Envelhecimento/fisiologia , Encéfalo/anatomia & histologia , Encéfalo/metabolismo , Imageamento por Ressonância Magnética , Caracteres Sexuais , Tomografia Computadorizada de Emissão , Adulto , Idoso , Idoso de 80 Anos ou mais , Encéfalo/fisiologia , Cognição/fisiologia , Feminino , Lobo Frontal/anatomia & histologia , Lobo Frontal/metabolismo , Lobo Frontal/fisiologia , Glucose/metabolismo , Hipocampo/anatomia & histologia , Hipocampo/metabolismo , Hipocampo/fisiologia , Humanos , Masculino , Memória/fisiologia , Pessoa de Meia-Idade , Testes Neuropsicológicos , Lobo Parietal/anatomia & histologia , Lobo Parietal/metabolismo , Lobo Parietal/fisiologia , Fatores Sexuais , Percepção Espacial/fisiologia , Fala/fisiologia , Lobo Temporal/anatomia & histologia , Lobo Temporal/metabolismo , Lobo Temporal/fisiologiaRESUMO
To assess muscle function after a period of negative energy balance, 32 obese women were placed on a 544-kcal/d, high-protein diet for 4 wk. Weight loss was associated with a decrease in the waist-to-hip-circumference ratio (WHR) and significantly higher emptying of abdominal than gluteal fat cells. The low-calorie regimen was associated with a significant increase in isokinetic muscle endurance, a decrease in glycogen concentration, and an increase in glycogen synthase (GS) activity and its fractional velocity (FV). The GS activity and its FV were negatively correlated with the WHR before treatment whereas their subsequent increase was correlated with the decrease in WHR. Dietary treatment produced a decrease in the isokinetic muscle strength, which was correlated with the reduction in lean body mass. The improvement in dynamic endurance observed after energy restriction parallels not only the increase in GS activity in muscle but also the decrease in glycogen stores and glucose oxidation, and most probably depends on the increased utilization of fatty acids.
Assuntos
Dieta Redutora , Ingestão de Energia , Músculos/fisiopatologia , Obesidade/fisiopatologia , Resistência Física , Redução de Peso , Tecido Adiposo/metabolismo , Tecido Adiposo/patologia , Adulto , Metabolismo Energético , Teste de Esforço , Ácidos Graxos/metabolismo , Feminino , Glucose/metabolismo , Glicogênio/metabolismo , Glicogênio Sintase/metabolismo , Humanos , Músculos/enzimologia , Músculos/metabolismo , Obesidade/enzimologia , Obesidade/metabolismo , OxirreduçãoRESUMO
A nonpharmacological approach in the treatment of mild hypertension is often advocated. In an attempt to decrease sodium and increase potassium intake, sixty-two middle-aged patients with mild hypertension were given a potassium loaded ion-exchanging sodium-adsorbing potassium-releasing seaweed preparation (seaweed fiber, SF). The mean blood pressure (MBP), evaluated in a double-blind crossover manner with four weeks familiarization and wash-out periods, showed a significant decrease after four weeks on 12 and 24 g/day SF but not on 6 g/day or placebo treatment. Systolic blood pressure during submaximal exercise decreased on all three SF doses. The decrease in MBP appeared to be significantly higher in sodium-sensitive (11.2 mm Hg, P less than .001) than in sodium-insensitive (5.7 mm Hg, P less than .05) patients and was in salt-sensitive patients significantly correlated to the increase in plasma renin activity (PRA). The urinary sodium excretion decreased, the urinary potassium increased and the sodium/potassium urinary excretion ratio decreased, indicating that the decrease of MBP was dependent on the decreased intestinal absorption of sodium and increased absorption of potassium released from the seaweed preparation. A sodium-potassium ion-exchanging seaweed preparation is an effective means of decreasing sodium and increasing potassium intake, and may be used for antihypertensive treatment in mild hypertension.
Assuntos
Proteínas de Transporte/fisiologia , Dieta Hipossódica , Hipertensão/fisiopatologia , Alga Marinha/fisiologia , Adulto , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Peso Corporal/efeitos dos fármacos , Colesterol/sangue , Feminino , Humanos , Hipertensão/dietoterapia , Ferro/sangue , Masculino , Pessoa de Meia-Idade , Potássio/urina , Renina/sangue , Sódio/farmacologia , Sódio/urina , Simportadores de Cloreto de Sódio-Potássio , Triglicerídeos/sangueRESUMO
To test the cognitive effects of aging and apolipoprotein E (APOE) in individuals at high risk for Alzheimer's disease (AD), we assessed APOE genotypes and performance on a battery of neuropsychological tests in 41 non-demented, Down syndrome (DS) adults. Old DS subjects (ages 41-61 years) showed poorer memory and orientation scores than young DS adults (ages 22-38 years), but the groups did not differ in other measures after we controlled for intellectual function. Language ability was inversely related to APOE genotype, even after age was controlled for, with the presence of the epsilon 2 allele corresponding to better language skills than epsilon 4. Age-related cognitive changes in non-demented DS adults are consistent with the early effects of AD. The relationship between basic linguistic skills and APOE genotype supports this genetic factor in influencing the development of dementia and AD neuropathology in DS.
Assuntos
Envelhecimento/fisiologia , Apolipoproteínas E/metabolismo , Cognição/fisiologia , Síndrome de Down/metabolismo , Síndrome de Down/psicologia , Adulto , Alelos , Síndrome de Down/fisiopatologia , Feminino , Marcadores Genéticos , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Fatores de RiscoRESUMO
In imaging studies of brain functions using pharmacological probes, identification of the time point at which central effects of intravenously infused drugs become stable is crucial to separate the effects of experimental variables from the concomitant changes in drug effects over time. We evaluated the time courses of the pharmacokinetics and pharmacodynamics, including butyrylcholinesterase inhibition and central neural responses, of physostigmine in healthy young subjects. Ten positron emission tomography (PET) scans that alternated between a rest condition (eyes open, ears unplugged) and a working memory for faces (WM) task were acquired in healthy subjects. Subjects in the drug group received a saline infusion for the first two scans, providing a baseline measure, then received an infusion of physostigmine for all subsequent scans. Subjects in the control group received a placebo infusion of saline for all scans. Physostigmine plasma levels and percent butyrylcholinesterase inhibition increased over time (p < 0. 0001), and both became stable by 40 min. Physostigmine decreased reaction time (RT) (p = 0.0005), and this effect was detected after 20 min of infusion and stable thereafter. Physostigmine also decreased regional cerebral blood flow (rCBF) in right prefrontal cortex during task (p = 0.0002), and this effect was detected after 40 min of infusion and stable thereafter. No change in RT or rCBF was observed in the control group. These results indicate that a 40-min infusion of physostigmine was necessary to obtain stable central effects. More generally, we have demonstrated that experimental effects can vary with time, especially during the initial phases of a drug infusion, indicating that it is critical that these changes are controlled.
Assuntos
Encéfalo/metabolismo , Fisostigmina/farmacocinética , Adulto , Análise de Variância , Encéfalo/diagnóstico por imagem , Encéfalo/efeitos dos fármacos , Inibidores da Colinesterase/farmacocinética , Inibidores da Colinesterase/farmacologia , Cognição/efeitos dos fármacos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fisostigmina/farmacologia , Desempenho Psicomotor/efeitos dos fármacos , Fatores de Tempo , Tomografia Computadorizada de EmissãoRESUMO
Thirty six obese women (BMI 29.5 to 44.0 kg m-2, aged 27 to 45 yrs) participated in the 4- week weight reducing program. All of them have prescribed low fat diet of approx. 4.2 MJ (1000 kcal per day) with high viscous fibre capsules as a basic supplement. In addition 18 women (group 1) received Redusan mineral tablets containing mainly calcium and potassium phosphates while the remaining subjects (group 2) were given Placebo instead of mineral tablets. Before energy restriction and after 4 weeks on the diet, half of the women from each group performed 30 min--bicycle ergometer exercise (30-50 W; HR approx. 110 beats.min-1). The remaining subjects were submitted to oral glucose (75 g) tolerance test (OGTT). Weight loss during energy restriction was not affected by phosphate supplementation (4.6 +/- 0.4 and 5.2 +/- 0.5 kg in group 1 and 2, respectively). Phosphates caused a significant increase (p < 0.05) in the resting metabolic rate (RMR). Net energy cost of work, resting and post-exercise blood glucose, lactate, plasma FFA, adrenalin, cortisol, growth hormone, insulin and testosterone did not differ between the groups receiving phosphates and placebo while respiratory exchange ratio was slightly higher (p < 0.05), and the plasma beta-hydroxybutyrate concentration lower (p < 0.05) than without phosphate supplementation. Post-exercise plasma noradrenaline was significantly lowered after 4 weeks of energy restriction in group 2 (on Placebo). Neither blood glucose, plasma insulin and noradrenaline responses to oral glucose ingestion nor the glucose induced thermogenesis were significantly affected by phosphate supplementation, whilst blood pressure increases following glucose load were reduced (p < 0.05). In conclusion, the present study confirmed a potential usefulness of phosphate supplementation during energy restriction in obese patients due to its effect on resting metabolic rate. The results did not, however, reveal any major alterations in the metabolic and hormonal responses to exercise or to glucose ingestion in comparison with placebo treatment.
Assuntos
Exercício Físico/fisiologia , Glucose/farmacologia , Obesidade/metabolismo , Fosfatos/farmacologia , Redução de Peso/fisiologia , Adulto , Glicemia/metabolismo , Pressão Sanguínea/efeitos dos fármacos , Catecolaminas/sangue , Feminino , Teste de Tolerância a Glucose , Frequência Cardíaca/efeitos dos fármacos , Humanos , Insulina/sangue , Obesidade/sangue , Obesidade/dietoterapia , Consumo de Oxigênio/efeitos dos fármacosRESUMO
Thirty overweight women participated in 8 week slimming program consisting of a self-controlled low-energy diet (4.2 MJ/day) supplemented with highly viscous fibres and mineral tablets containing calcium, potassium and sodium phosphates (Redusan Combi, Biokraft Pharma AB, Sweden). Half of the patients received in double blind manner mineral tablets during first 4 weeks and placebo (without phosphates) during next 4 weeks (group 1) while the remaining patients were treated (cross-over) with placebo first and mineral tablets in the final period (group 2). The rate of weight loss was similar in groups 1 and 2 (4.7 vs 5.2 kg during the first 4 weeks and 2.7 vs 3.0 kg in the further 4 weeks). During periods of phosphate supplementation, the resting metabolic rate (RMR) increased by approx. 12% (p < 0.05) in group 1 and 19% (p < 0.05) in group 2. Phosphate supplementation ameliorated also a decrease in plasma triiodothyronine level and a decrease in thyroxine to triiodothyronine ratio. There were no differences between groups in the plasma insulin, catecholamine, growth hormone, cortisol and testosterone levels. Phosphate supplementation did not affect plasma lipids or blood glucose concentration. It is concluded that phosphate supplementation in obese patients on a low-energy diet enhances RMR irrespectively of the rate of weight loss. This effect seems to be, at least partly, due to an influence of phosphates on peripheral metabolism of thyroid hormones.
Assuntos
Peso Corporal , Obesidade/dietoterapia , Fosfatos/administração & dosagem , Tri-Iodotironina/sangue , Adulto , Dieta Redutora , Método Duplo-Cego , Ingestão de Energia , Metabolismo Energético , Feminino , Humanos , Pessoa de Meia-Idade , Obesidade/sangue , Consumo de Oxigênio/fisiologiaRESUMO
BACKGROUND AND PURPOSE: Advanced age and hypertension have each been associated with changes in brain morphology and cognitive function. To investigate the interaction of age and hypertension with structural brain changes and neuropsychological performance in otherwise healthy patients with essential hypertension, we compared young-old (ages 56 to 69 years) and old-old (ages 70 to 84 years) hypertensive patients (n = 27) with 20 age-matched normotensive healthy control subjects, using quantitative volumetric MRI and a battery of neuropsychological tests. METHODS: Quantitative regions of interest and segmentation analyses were applied to MRI scans of brain to measure volumes of different brain structures and of cerebrospinal fluid (CSF). Severity of white matter hyperintensities (WMHs) was qualitatively rated in the MRI scans. A battery of neuropsychological tests was administered to each subject. RESULTS: The combined hypertensive group (young-old and old-old) had smaller volumes of thalamic nuclei and larger volumes of CSF in the cerebellum and temporal lobes and showed poorer performance in memory and language tests than did the control subjects. Main effects for age were significant in multiple brain regions of interest. The old-old hypertensive patients and age-matched control subjects demonstrated volume reductions in brain structures and increases in ventricular and peripheral CSF volumes compared with the younger subjects. There was a significant group x age-group interaction in temporal and occipital CSF, not related to WMH, with the old-old hypertensive patients having significantly larger CSF volumes in these regions than the young-old hypertensives and both healthy control groups. CONCLUSIONS: Hypertension exacerbates the morphological changes accompanying advanced age. Temporal and occipital regions appear most vulnerable to brain atrophy due to the interactive effects of age and hypertension.